Surg: Breast Cancer: Free MSRA Podcast

🎧Breast Cancer – YourComplete MSRA Deep Dive 🎗️🩺Welcome to another high-impact MSRA Deep Dive, where we break downBreast Cancer—the most common cancer inwomen in the UK. Whether you're prepping for exams like the MSRA or simply want a clear grasp of thefundamentals, this episode gives you the full picture: definition, risk factors, development, diagnosis, management,complications, and prognosis.🩺What You’ll Learn:• Definition: – Breast cancer isa malignant tumour of breast tissue, mostoften arising from ductal or lobular cells – Key feature: uncontrolled growth and potential to invade and metastasise🧬Etiology:– A multifactorial disease driven by: • Genetic mutations (e.g., BRCA1, BRCA2) • Hormonal exposure (early menarche, latemenopause, HRT) • Lifestyle & environmental factors (obesity,alcohol, lack of breastfeeding)📋Key Risk Factors (mnemonic: FABHIPNOP):F – FemaleA – Age (riskincreases with age)B – Bloodline(family history, BRCA mutations)H – Hormones (HRT,early periods, late menopause, pregnancy >30)I – Inherited genes(e.g., TP53)P – Previous benignbreast issuesN – NotbreastfeedingO – Obesity(especially post-menopause)P – Personal historyof breast cancer🦠Pathophysiology:– Genetic mutations→ abnormal cell growth– Formation of atumour → invasion of surrounding tissue– Spread via lymphatics (e.g., axillary nodes)and blood → metastasis📋DifferentialDiagnosis:– Fibroadenoma– Breast cysts– Fibrocystic changes– Fat necrosis– Inflammatory breast cancer– (Not all lumps =cancer!)📊Epidemiology (UK):– ~54,000 cases/year– ~11,000 deaths/year– Most common in women >50, but can affect younger adults andmen too🔍Clinical Presentation (mnemonic: LUMP-S-IN):L – LumpU – Unexplainedshape or size changeM – Marked skinchanges (dimpling, redness)P – Nipple inversionor dischargeS – Swollen lymphnodesIN – Inflammatorysigns in rare subtypes🧪Investigations:– Triple assessment: 1. Clinical exam 2. Imaging: mammogram, ultrasound, MRI 3. Biopsy: core needle or FNA– Additional:Hormone receptor status (ER/PR), HER2 testing, BRCA testing (if relevant)🔬Types:– Invasive ductal carcinoma (most common)– Invasive lobular carcinoma– Ductal carcinoma in situ (DCIS)– HER2+,triple-negative, ER+/PR+ subtypes🛠️Management (multidisciplinary approach):• Surgery: lumpectomy or mastectomy ±reconstruction• Radiotherapy: often after lumpectomy• Hormone therapy: – Tamoxifen (premenopausal) – Aromatase inhibitors (postmenopausal)• Targeted therapy: trastuzumab (HER2+)• Chemotherapy: neoadjuvant/adjuvant depending onstage• Ongoing follow-up & surveillance📈Prognosis:– Highly stage-dependent– Early detection =excellent outcomes– 5-year survival often >85% in early-stagecases– Improvements dueto screening and tailored treatments⚠️Complications:– Metastasis: bones, liver, lungs, brain– Lymphedema (from lymph node removal orradiotherapy)– Psychological effects, fatigue, menopausalsymptoms– Chemo side effects: hair loss, nausea– Late complications: recurrence, cardiotoxicityfrom trastuzumab💬Key Takeaways:– BRCA ≠ diagnosis, but increased risk– Most breast lumps aren’t cancer, but all should be checked– Use urgent 2-week wait referral pathways when red flagsare present– Personalised,multi-modal care = best outcomes📚Your Breast CancerStudy Kit:• 📘 Revision Notes:https://www.passthemsra.com/topic/breast-cancer-revision-notes-2/• 🃏 Flashcards:https://www.passthemsra.com/topic/breast-cancer-flashcards-2/• 📂 Accordion Q&A:https://www.passthemsra.com/topic/breast-cancer-accordion-qa-notes-2/• 🎯 Rapid Quiz:https://www.passthemsra.com/topic/breast-cancer-rapid-quiz-2/🌐 For more MSRA resources:https://www.passthemsra.comhttps://www.freemsra.com#MSRA #BreastCancer#MSRARevision #MSRAFlashcards #MSRAQuiz #SurgeryMSRA #BRCA #HER2 #Tamoxifen#NICEGuidelines #PassTheMSRA #FreeMSRA